Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Omeprazole sodium shows competitive inhibition of CYP2C19 activity with a Ki of 2 to 6 μM
Twenty-four hours after po administration
InChiKey: IWASCEKXRLUKKH-GVDBMIGSSA-N
Smiles: [2H]C1=C(C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)C4C=CC=CC=4)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)OC(C)=O)C2C=CC=CC=2)C([2H])=C([2H])C([2H])=C1[2H]
DJ001 treatment also significantly increases the numbers of colony forming cells (CFCs) in 3 day culture of BM KSL cells
Neoruscogenin Catalog No.:M19094-C Omeprazole sodium shows competitive inhibitionNeoruscogenin, a member of the steroidal sapogenin family, is a bioavailable, potent, and high affinity agonist of the nuclear receptor ROR (NR1F1). Product information CAS Number: 17676 33 4 Molecular Weight: 428. 60 Formula: C27H40O4 Chemical Name: (1'S,2R,2'S,4'S,7'S,8'R,9'S,12'S,13'R,14'R,16'R) 7',9',13' trimethyl 5 methylidene 5' oxaspiro[oxane 2,6' pentacyclo[10. 8. 0. 0,. 0,. 0,]icosan] 18' ene 14',16' diol Smiles:
US$ 469.50
US$ 1232.00
US$ 2296.50
US$ 662.50
US$ 811.00
US$ 785.00
US$ 658.50
US$ 1494.00
US$ 3194.00
US$ 1252.00
US$ 2202.00
US$ 694.50